A carregar...
The Role of Everolimus in Renal Cell Carcinoma
Everolimus (RAD001) is an orally administered agent that inhibits the mammalian target of rapamycin serine-threonine kinase. A phase III pivotal trial on everolimus, published in 2008, provided the first evidence for the efficacy of sequential therapy for patients with metastatic clear cell renal ce...
Na minha lista:
| Publicado no: | J Kidney Cancer VHL |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Codon Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5345521/ https://ncbi.nlm.nih.gov/pubmed/28326273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15586/jkcvhl.2015.43 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|